BIOMAT Database Logo BIOMAT Database Logo

[Primary serological screening of the infection caused by the LAV/HTLV-III/HIV virus in Moscow]. 1987

V V Pokrovskiĭ, and Z K Iankina, and L M Toporovskiĭ, and V G Ryvkina, and V I Pokrovskiĭ

The screening covering 5,155 residents of Moscow and 6,412 foreign students revealed the presence of antibodies to the virus, causing immunodeficiency in man, in 20 students from African countries. The antibodies were detected by means of the immune blotting assay. The problem of the possibility of the heterosexual transfer of the virus is discussed.

UI MeSH Term Description Entries
D008297 Male Males
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D009031 Moscow The capital of Russia.
D005060 Europe The continent north of AFRICA, west of ASIA and east of the ATLANTIC OCEAN. Northern Europe,Southern Europe,Western Europe
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000349 Africa The continent south of EUROPE, east of the ATLANTIC OCEAN and west of the INDIAN OCEAN.
D000569 Americas The general name for NORTH AMERICA; CENTRAL AMERICA; and SOUTH AMERICA unspecified or combined. America
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

V V Pokrovskiĭ, and Z K Iankina, and L M Toporovskiĭ, and V G Ryvkina, and V I Pokrovskiĭ
[Pathology of HTLV III/LAV virus infection].
January 1986, Pathologica,
V V Pokrovskiĭ, and Z K Iankina, and L M Toporovskiĭ, and V G Ryvkina, and V I Pokrovskiĭ
[Three names--one virus: HTLV-III/LAV/HIV].
August 1987, Die Quintessenz,
V V Pokrovskiĭ, and Z K Iankina, and L M Toporovskiĭ, and V G Ryvkina, and V I Pokrovskiĭ
[Cellular immune response in HIV(LAV/HTLV-III) infection].
November 1986, Schweizerische medizinische Wochenschrift,
V V Pokrovskiĭ, and Z K Iankina, and L M Toporovskiĭ, and V G Ryvkina, and V I Pokrovskiĭ
[Immunofluorescence in the serological study of HTLV-III/LAV].
January 1986, Medicina,
V V Pokrovskiĭ, and Z K Iankina, and L M Toporovskiĭ, and V G Ryvkina, and V I Pokrovskiĭ
[Acute LAV/HTLV III infection].
January 1986, Nordisk medicin,
V V Pokrovskiĭ, and Z K Iankina, and L M Toporovskiĭ, and V G Ryvkina, and V I Pokrovskiĭ
[The genome of HIV (HTLV-III, LAV), the human immunodeficiency virus].
January 1987, Postepy biochemii,
V V Pokrovskiĭ, and Z K Iankina, and L M Toporovskiĭ, and V G Ryvkina, and V I Pokrovskiĭ
Transmission of HTLV III/LAV infection.
October 1986, Indiana medicine : the journal of the Indiana State Medical Association,
V V Pokrovskiĭ, and Z K Iankina, and L M Toporovskiĭ, and V G Ryvkina, and V I Pokrovskiĭ
[HTLV III/LAV (AIDS)-infection protection].
July 1986, Quintessenz Journal,
V V Pokrovskiĭ, and Z K Iankina, and L M Toporovskiĭ, and V G Ryvkina, and V I Pokrovskiĭ
AIDS update: HTLV-III/LAV infection.
January 1986, Pennsylvania medicine,
V V Pokrovskiĭ, and Z K Iankina, and L M Toporovskiĭ, and V G Ryvkina, and V I Pokrovskiĭ
Serological differences between human T-lymphotropic virus type-I (HTLV-I) and HTLV-III/LAV.
January 1986, Microbiology and immunology,
Copied contents to your clipboard!